genomics

Analysis of two pivotal Yescarta clinical trials revealed that patients' germline DNA influences both toxicity risk and CAR T expansion, opening new opportunities for smarter cell therapy design.

Learn how to accelerate nucleic acid quantification while improving accuracy and reducing variability in high-throughput genomic workflows.

Take a closer look at how single-molecule PCR approaches enable characterization of DNA impurity integrity beyond standard quantification in rAAV manufacturing.

Unexpected breakthroughs in drug manufacturing, lawsuits, regulatory updates, and more led the news this week.

Machine learning helps translate complex DNA fragment patterns into disease-specific signatures, offering a new path for early detection.

A new biological foundation model analyzes genomic patterns across the tree of life and may accelerate disease research and synthetic biology.

A new model combines high-resolution experimental data with deep learning to reveal how non-coding DNA sequences control gene activity across different cell types.

Large-scale clinicogenomic data sheds light on the biology of rare kidney disorders and opens doors to new treatment possibilities.

Researchers challenge decades-old assumptions about fragile protein cores, opening new paths for faster drug and enzyme design.

Investment to leverage OutSee’s proprietary AI-based predictive genomics technology, Nomaly, to expand and progress in-house target development program